Tag: Bayer

Bayer AG is a German multinational chemical, pharmaceutical and life sciences company. It is headquartered in Leverkusen, where its illuminated sign is a landmark. Bayer’s primary areas of business include human and veterinary pharmaceuticals; consumer healthcare products; agricultural chemicals and biotechnology products; and high value polymers.

Bayer Animal Health GmbH and VLPbio Signed Global Collaboration Agreement

Bayer Animal Health GmbH and VLPbio – The Vaccines Company S.L. have signed a global collaboration agreement to discover and develop a new generation of immunotherapeutic solutions that address the hi...

FDA Approved Xarelto™ for Venous Thromboembolism Prevention

Bayer AG and its development partner Janssen Research & Development, LLC announced that the U.S. Food and Drug Administration (FDA) has approved rivaroxaban (Xarelto™) for the prevention of venous...

Bayer’s Otic Solution Neptra® Received Positive Opinion of EMA’s CVMP

Bayer's Otic Solution Neptra® (florfenicol, terbinafine hydrochloride, mometasone furoate) has now received, the positive opinion of the Committee for Medicinal Products for Veterinary Use (CVMP) of t...

Bayer Signed Collaboration Agreements with 11 Digital Health Startups

Bayer announced that the company has signed collaboration agreements with eleven digital health startups. As part of the program, Bayer will support these startup companies aiming for longer-term c...

Bayer Launched LifeHub UK to Accelerate Disease Detection and Drug Discovery

bayer
Bayer launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solutions. The new hub is the seventh pillar...

Bayer and Partners Launched Joint Lab to Research New Drug Candidates to Treat Chronic Lung Diseases...

Bayer and Partners HealthCare’s founding members Brigham and Women’s Hospital (BWH) and Massachusetts General Hospital (MGH) announced the launch of a joint lab to research new drug candidates to trea...

European Commission Granted Marketing Authorization for Bayer Vitrakvi®

Bayer
Bayer announced that the European Commission has granted marketing authorization in the European Union (EU) for the precision oncology treatment Vitrakvi® (larotrectinib). The drug is indicated for...

Bayer Entered Commercial Licensing Agreement with One Drop

One Drop announced $40 million in Series B financing, led by pharmaceutical company, Bayer. Additionally, Bayer has entered a commercial licensing agreement to use One Drop's platform in Bayer's globa...

Bayer Foundation Launched New Social Innovation Ecosystem Fund

Bayer
The Bayer Foundation launched its new EUR 20 million Social Innovation ecosystem fund by awarding EUR 3 million to four pioneering social innovators – myAgro, MercyCorps, Path and Living Goods. The fu...

Bayer Completed Sale of the Coppertone™ Brand

Bayer announced the completion of the sale of the Coppertone™ brand to Beiersdorf for a purchase price of 550 million U.S. dollars. In May of this year, Bayer entered into a definitive agreement to se...

Bayer Animal Health Launched Drontal™ Plus Tasty in China

bayer
In August, Bayer Animal Health launched Drontal™ Plus Tasty in China. The product is an upgrade of Drontal™ Plus Flavor and offers new innovative key features. Drontal is one of the most widely use...

Elanco Animal Health Entered into Definitive Agreement to Acquire Bayer’s Animal Health Business

U.S.-based company Elanco Animal Health has entered into a definitive agreement to acquire Bayer’s Animal Health business. The transaction is valued at 7.6 billion U.S. dollars consisting of 5.3 billi...

Bayer Announced Acquiring of BlueRock Therapeutics

Bayer AG and BlueRock Therapeutics announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on developing engi...

NICE Recommended Bayer’s Xarelto for Preventing Atherothrombotic Events

Bayer’s Xarelto (rivaroxaban) can be funded by the NHS to prevent strokes and heart attacks in high-risk adults with coronary artery disease, NICE has said. In the final draft guidance, NICE recomm...

FDA Approved Bayer’s Non-Steroidal Androgen Receptor Inhibitor

The U.S. Food and Drug Administration (FDA) has approved darolutamide, a non-steroidal androgen receptor inhibitor (ARi), under the brand name Nubeqa®. The FDA approval is for the treatment of pati...

Bayer and WRA Renewed Partnership to Improve Every Day Health of Women, Infants and Children

bayer
Bayer and White Ribbon Alliance (WRA) announced they will extend their partnership and expand their initiative to help women in low and middle income countries gain the knowledge and confidence needed...